---
title: "Lactiplantibacillus plantarum LP28 Boosts NK Activity and Lowers Cold Incidence in Older Adults"
id: "medrxiv-2-the-influence-of-long-term-supplementation-with-lactiplantibacillus-plantarum"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-the-influence-of-long-term-supplementation-with-lactiplantibacillus-plantarum"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1?rss=1"
published_at: "2026-11-10T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Lactiplantibacillus plantarum LP28 Boosts NK Activity and Lowers Cold Incidence in Older Adults
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-the-influence-of-long-term-supplementation-with-lactiplantibacillus-plantarum
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1?rss=1)
- **Published At:** 2026-11-10T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Randomized, double-blind, placebo-controlled trial over 12 weeks assessed oral **Lactiplantibacillus plantarum LP28** supplementation in adults aged 50–75 years. - Dosing reported: 5 × 10^9 CFU per capsule, two capsules daily; treatment arm n = 51, placebo n = 51. - Upper respiratory symptom incidence and severity were measured by the Wisconsin Upper Respiratory Symptom Survey (WURSS); investigators reported a lower cold incidence in the probiotic group (34.78%) versus placebo (52.00%). - The study team quantified immune endpoints using flow cytometry, ELISAs, and NK cell cytotoxicity assays; analyses used per-protocol and outlier-removed sensitivity approaches. - Supplementation was associated with increased serum **interleukin-12 (IL-12)** and enhanced **NK cell** cytotoxicity, indicating activation of an IL-12/NK axis. - Data indicated a reduction in the inflammatory marker **C-reactive protein (CRP)** in the probiotic arm. - Statistical comparisons employed independent t tests, chi-square/Fisher exact tests, and Mann-Whitney U tests as appropriate. - Ethical approval obtained (Taichung Veterans General Hospital IRB Protocol No. SF24108C); trial registered NCT06724185. - The article discloses industry affiliation for several authors; data are available from the corresponding author on request. - The source did not report detailed adverse event breakdowns or long-term follow-up beyond 12 weeks, and mechanistic dosing-response curves were not provided in the report.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=hpzlWEZmSKSZ16nRdJrq_JnlQSzww4Mt_hCFJZsjhk0-1794354035.492617-1.2.1.1-sn_18bLeA3n6GLDKkoCc8zUuBCrKn3mOCzomfBODz9TOaPUOb_fF3qUnsVt6xazW) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # The Influence of Long-Term Supplementation with Lactiplantibacillus plantarum LP28 on NK Cell Activity and Upper Respiratory Symptoms in Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial Zheng-Yi Li, Mei-Hui Tseng, Chung-Min Shieh, Mao-Chia Chang, Han-Yin Hsu, Chia-Chia Lee, Hsiao-Wen Huang, Ching-Lin Wu, [ View ORCID Profile](http://orcid.org/0000-0001-8412-3603)Jeng-Jer Shieh doi: https://doi.org/10.64898/2026.11.08.26367495 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Zheng-Yi Li 1 Institute of Biomedical Sciences, National Chung Hsing University, Taichung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zheng-Yi%2BLi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Li%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AZheng-Yi%2BLi%2B) Mei-Hui Tseng 1 Institute of Biomedical Sciences, National Chung Hsing University, Taichung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mei-Hui%2BTseng%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tseng%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMei-Hui%2BTseng%2B) Chung-Min Shieh 2 Department of Mathematics, National Cheng Kung University, Tainan City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chung-Min%2BShieh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shieh%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChung-Min%2BShieh%2B) Mao-Chia Chang 1 Institute of Biomedical Sciences, National Chung Hsing University, Taichung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mao-Chia%2BChang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chang%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMao-Chia%2BChang%2B) Han-Yin Hsu 3 Culture Collection & Research Institute, SYNBIO TECH INC., Kaohsiung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Han-Yin%2BHsu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hsu%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHan-Yin%2BHsu%2B) Chia-Chia Lee 3 Culture Collection & Research Institute, SYNBIO TECH INC., Kaohsiung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chia-Chia%2BLee%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lee%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChia-Chia%2BLee%2B) Hsiao-Wen Huang 3 Culture Collection & Research Institute, SYNBIO TECH INC., Kaohsiung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hsiao-Wen%2BHuang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Huang%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHsiao-Wen%2BHuang%2B) Ching-Lin Wu 4 Graduate Institute of Sports and Health Management, National Chung Hsing University, Taichung City, Taiwan * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ching-Lin%2BWu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Wu%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChing-Lin%2BWu%2B) Jeng-Jer Shieh 1 Institute of Biomedical Sciences, National Chung Hsing University, Taichung City, Taiwan; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jeng-Jer%2BShieh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shieh%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJeng-Jer%2BShieh%2B) * [ORCID record for Jeng-Jer Shieh](http://orcid.org/0000-0001-8412-3603 "Open in new tab") * For correspondence: shiehjj@dragon.nchu.edu.tw * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1341646/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1341646/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1341646/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1341646/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1341646/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1341646/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Population aging and immunosenescence pose immense challenges to healthcare systems by increasing susceptibility to infections. Lactiplantibacillus plantarum LP28 (L. plantarum LP28) is a strain isolated from traditional Taiwanese dried tofu with significant immunomodulatory potential. Objective: To evaluate the clinical efficacy of long-term L. plantarum LP28 supplementation in common cold prevention and its effect on systemic immune biomarkers in middle-aged and elderly individuals. Methods: In this 12-week, randomized, double-blind, placebo-controlled trial, 102 middle-aged and older adults (aged 50-75 years) were assigned to receive an oral probiotic (5 x 109 CFU L. plantarum LP28/capsule, two capsules daily; n = 51) or a placebo (n = 51). Cold incidence and symptom severity were evaluated by the Wisconsin Upper Respiratory Symptom Survey (WURSS). Immune cell populations, serum/salivary markers, and natural killer (NK) cell activity were quantified using flow cytometry, ELISAs and NK cell cytotoxicity assays, respectively. The data were analyzed using a refined per-protocol approach and outlier-removed sensitivity analyses to ensure robustness. Independent t tests, chi-square/Fisher's exact tests, and Mann-Whitney U tests were used for statistical comparisons. Results: The probiotic group exhibited a notable reduction in cold incidence (34.78% vs. 52.00% in the placebo group) and a lower cumulative symptom burden. In terms of immunomodulatory effects, L. plantarum LP28 supplementation significantly increased serum interleukin (IL)-12 levels and NK cell cytotoxicity, reinforcing innate immune defense through the activation of the IL-12/NK cell axis. This was accompanied by a significant reduction in the level of the inflammatory marker C-reactive protein (CRP). Conclusions: L. plantarum LP28 supplementation serves as an effective supportive strategy for promoting healthy aging by increasing respiratory defense resilience and mitigating systemic inflammatory stress through pleiotropic immune modulation. ### Competing Interest Statement H.-Y.H., C.-C.L. and H.-W.H. are employed by SYNBIO TECH INC. J.-J.S., C.-L.W., Z.-Y.L., M.-H.T., C.-M.S. and M.-C.C. declare no conflicts of interest. ### Clinical Trial NCT06724185 ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approval for this work was given by the Institutional Review Board of Taichung Veterans General Hospital (Protocol No. SF24108C). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The data presented in this study are available on request from the corresponding author. ## Funder Information Declared UniversityIndustry Cooperation Fund, National Chung-Hsing University, Taichung City, Taiwan, 113D530 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.09.26367657v1 "PNEUMOCOCCAL CONJUGATE VACCINE SCHEDULES SHAPE SEROTYPE-SPECIFIC MEMORY B-CELL RESPONSES")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.09.26367638v1 "Effect of starting metformin on severe and long COVID-19 among people living with type 2 diabetes in England: a new user cohort study in OpenSAFELY-TPP") Posted November 10, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/10/2026.11.08.26367495.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.08.26367495v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/10/2026.11.08.26367495.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) The Influence of Long-Term Supplementation with Lactiplantibacillus plantarum LP28 on NK Cell Activity and Upper Respiratory Symptoms in Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial Zheng-Yi Li, Mei-Hui Tseng, Chung-Min Shieh, Mao-Chia Chang, Han-Yin Hsu, Chia-Chia Lee, Hsiao-Wen Huang, Ching-Lin Wu, Jeng-Jer Shieh medRxiv 2026.11.08.26367495; doi: https://doi.org/10.64898/2026.11.08.26367495 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.08.26367495v1%26text%3DThe%2520Influence%2520of%2520Long-Term%2520Supplementation%2520with%2520Lactiplantibacillus%2520plantarum%2520LP28%2520on%2520NK%2520Cell%2520Activity%2520and%2520Upper%2520Respiratory%2520Symptoms%2520in%2520Middle-Aged%2520and%2520Older%2520Adults%253A%2520A%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.08.26367495v1%26t%3DThe%2520Influence%2520of%2520Long-Term%2520Supplementation%2520with%2520Lactiplantibacillus%2520plantarum%2520LP28%2520on%2520NK%2520Cell%2520Activity%2520and%2520Upper%2520Respiratory%2520Symptoms%2520in%2520Middle-Aged%2520and%2520Older%2520Adults%253A%2520A%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.08.26367495v1%26title%3DThe%2520Influence%2520of%2520Long-Term%2520Supplementation%2520with%2520Lactiplantibacillus%2520plantarum%2520LP28%2520on%2520NK%2520Cell%2520Activity%2520and%2520Upper%2520Respiratory%2520Symptoms%2520in%2520Middle-Aged%2520and%2520Older%2520Adults%253A%2520A%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.08.26367495v1%26title%3DThe%2520Influence%2520of%2520Long-Term%2520Supplementation%2520with%2520Lactiplantibacillus%2520plantarum%2520LP28%2520on%2520NK%2520Cell%2520Activity%2520and%2520Upper%2520Respiratory%2520Symptoms%2520in%2520Middle-Aged%2520and%2520Older%2520Adults%253A%2520A%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.08.26367495v1&count=horizontal&via=&text=The%20Influence%20of%20Long-Term%20Supplementation%20with%20Lactiplantibacillus%20plantarum%20LP28%20on%20NK%20Cell%20Activity%20and%20Upper%20Respiratory%20Symptoms%20in%20Middle-Aged%20and%20Older%20Adults%3A%20A%20Randomized%2C%20Double-Blind%2C%20Placebo-Controlled%20Trial&counturl=www.medrxiv.org/content/10.64898/2026.11.08.26367495v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (919) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5013) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (428) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (678) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1695) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16280) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1241) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7288) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1093) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5301) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1470) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1835) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16499) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrolog
## Related Clinical Research

- [High-Fiber Diet Outperforms Metformin in Blood Sugar Control and Weight Loss](https://medichelpline.com/clinical-feed/medical-news-today-0-high-fiber-diet-vs-metformin-which-is-better-for-blood-sugar-control-weight-loss.md)
- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)
- [Metformin and Severe Post-COVID-19 Outcomes Among Individuals with Diabetes Mellitus](https://medichelpline.com/clinical-feed/medrxiv-9-metformin-and-severe-post-covid-19-outcomes-among-individuals-with-diabetes.md)
- [Parenchymal Neuro-Behçet Disease Case Report: Heterogeneous Clinical Presentations](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-parenchymal-neuro-beh-et-disease-with-heterogeneous-clinical-presentations-a.md)
- [Efgartigimod for anti-GAD65 antibody–positive epilepsy and cerebellar ataxia: case report overview](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-treatment-of-anti-gad65-antibody-positive-epilepsy-and-cerebellar-ataxia-with.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.